For CYP2R1 rs10741657 polymorphism, the dominant model revealed that patients with the A allele presented a higher risk of developing COPD (p = 0.018; OR = 1.59; 95% CI = 1.09-2.34, A vs. GG; Table 2). Here, CYP2R1 is linked to chronic obstructive pulmonary disease.